Peptide formulations containing propylene glycol that are optimal for production and for use in injection devices

摘要

A pharmaceutical formulation comprising the Arg34 peptide, Lys26 (Nε- (γ-Glu (Nα-hexadecanoyl))) - GLP-1 (7-37) and propylene glycol, wherein said propylene glycol is present in said formulation in a final concentration of from 1 mg / mL to 100 mg / mL and where said formulation has a pH from 7.0 to 10.0.